Novartis shares experienced a significant decline following disappointing results from the del desiran drug trial, impacting investor confidence.
Read More
The Geo Chronicle
Your Window to World Affairs
YOU MAY HAVE MISSED
Your Window to World Affairs
Novartis shares experienced a significant decline following disappointing results from the del desiran drug trial, impacting investor confidence.
Read More